Sort
82,697 grants matching “vaccine development”
Pacific Ovarian Cancer Research Consortium
$2,296,158Nicole D. Urban · Fred Hutchinson Cancer Research Center · P50 · FY2012 · CA
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,296,028Scott M Hammer · Columbia University Health Sciences · U01 · FY2011 · AI
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT)
$2,295,742Abhijit Prakash Limaye · University Of Washington · U01 · FY2021 · AI
COBRE: Center for Computational Biology of Human Disease
$2,295,070David M Rand · Brown University · P20 · FY2022 · GM
NOVEL MUCOSAL VACCINE APPROACHES FOR PNEUMONIA.
$2,294,805Elizabeth Norton · Tulane University Of Louisiana · N01 · FY2022 · AI
The Immunobiology of Marrow Allografts for Leukemia
$2,294,717Sloan-Kettering Institute For Cancer Res · P01 · FY2003 · CA
PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE)
$2,294,182Robert Miller · Johns Hopkins University · N01 · FY2014 · AI
IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER
$2,293,769Dartmouth College · P20 · FY2001 · RR
Robust T-cell Immunity to Influenza in Human Populations
$2,292,639Bloodcenter Of Wisconsin, Inc. · U19 · FY2004 · AI
Center for Cancer Immunology and Immunotherapy (CCII)
$2,292,575Jun Yan · University Of Louisville · P20 · FY2024 · GM
Defining regulators of immunity to acute infection using CRISPR screens
$2,292,456Arlene H Sharpe · Harvard Medical School · U19 · FY2021 · AI
Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa
$2,292,400W. Henry Henry Boom · Case Western Reserve University · R01 · FY2016 · AI
HIV/SIV Data Base and Analysis Unit
$2,292,338National Institute Of Allergy And Infectious Diseases · Y01 · FY2017 · AI
Resources at the Caribbean Primate Research Center
$2,290,876Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2025 · OD
Pacific Ovarian Cancer Research Consortium
$2,290,683Nicole D. Urban · Fred Hutchinson Cancer Research Center · P50 · FY2009 · CA
Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU
$2,290,646Daniel R Kuritzkes · Massachusetts General Hospital · UM1 · FY2013 · AI
Resources at the Caribbean Primate Research Center
$2,290,432Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2024 · OD
Innovative Strategies to Combat Antibiotic-resistant Infections
$2,290,304Scott J Hultgren · Washington University · U19 · FY2023 · AI
Preventive Vaccines for HIV
$2,289,324Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Adjuvant Development Program: Leading to an Opioid Vaccine
$2,289,273Ofer Levy · Boston Children'S Hospital · N01 · FY2019 · AI
Randomized Trial of High-Dose Rifampin in Patients with New Smear-Positive TB
$2,289,159Carole D Mitnick · Harvard Medical School · U01 · FY2013 · AI
Flow Cytometry Core
$2,289,001Stephen Perfetto · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,288,273Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2025 · AG
Targets of antibody responses in vaccinia virus & protection mechanisms
$2,288,019Bjoern Peters · La Jolla Institute For Immunology · N01 · FY2012 · AI
Molecular approaches to understand vector-host and vector-pathogen interactions
$2,287,790Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI